Traws Pharma, Inc. Common Stock
TRAWTraws Pharma, Inc. (TRAW) is a biotechnology company focusing on the development of innovative pharmaceutical products. The company is dedicated to researching and bringing to market therapies aimed at addressing unmet medical needs, with a particular emphasis on novel formulations and delivery systems. Traws Pharma aims to leverage cutting-edge science to improve patient outcomes across various therapeutic areas.
Company News
Traws Pharma initiated Phase 2 clinical trials for ratutrelvir, a ritonavir-free COVID-19 treatment, comparing its safety and efficacy against PAXLOVID®. The company expects to report trial results by year-end 2025, targeting potential improvements in COVID treatment.
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 75% and 6.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch of proposed underwritten public offering of common shares. Flora Growth shares tumbled 20.2% to $2.13 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers HWH International Inc. (NASD...
